Stay updated on Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:33:52.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-07T00:43:36.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Access to the study record now shows a 403 Forbidden page instead of the usual study details. This indicates an access restriction rather than a content update to the record.
    Difference
    20%
    Check dated 2026-09-23T00:44:03.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a new version of the page metadata.
    Difference
    0.0%
    Check dated 2026-09-15T23:52:57.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    - Revision: v3.6.6 has been added, replacing Revision: v3.6.5. This reflects an update to the page template or rendering version.
    Difference
    0.0%
    Check dated 2026-09-01T18:57:30.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added to the study page to indicate the current version of the record. The Plain Language Summary and the earlier revision note v3.6.4 have been removed, altering how the study is presented to readers.
    Difference
    0.1%
    Check dated 2026-08-11T19:04:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab Combo in NSCLC Clinical Trial page.